[CAS NO. 332108-65-3]  ABMA

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [332108-65-3]

Catalog
AS983827
Brand
Arctom Scientific
CAS
332108-65-3

DESCRIPTION [332108-65-3]

Overview

MDL-
Molecular Weight350.29
Molecular FormulaC18H24BrNO
SMILESCOC1=CC=C(Br)C=C1CNC2(C3)CC4CC3CC(C4)C2

For research use only. We do not sell to patients.

Summary

ABMA is a broad-spectrum inhibitor of intracellular toxins and pathogens. ABMA efficiently protects cells against various toxins and pathogens including viruses , intracellular bacteria and parasite . ABMA selectively acts at host cell late endosomes rather than targeting toxin or pathogen itself. ABMA has broad-spectrum anti-infection activity [1] [2] .


IC50 & Target

Intracellular bacteria [1]
Viruses [1]
Parasite [1]


In Vitro

ABMA protects cells against four bacterial toxins ( Corynebacterium diphtheriae (DT; EC 50 of 62.9 μM), Bacillus anthracis (LT), Clostridium difficile toxin B (TcdB; EC 50 of 73.3 µM), Clostridium sordellii lethal toxin (TcsL; EC 50 of 86.7 μM)), three viruses (Ebola (EC 50 of 3.3 µM), rabies (EC 50 of 19.4 µM), dengue-4 virus ( EC 50 of 8.2 µM)), two species of Chlamydiales intracellular bacteria ( Simkania negevensis and Chlamydia trachomatis ), and the parasite Leishmania infantum (EC 50 of 7.1 µM) at micromolar level [1] .
In A549 cells, ABMA treatment induces a decrease in ricin cytotoxicity with an EC 50 of 3.8 µM, and a protection factor (R) at 30 µM ranging from 5 to 10. ABMA retained almost 100% of its biological activity against ricin-induced cytotoxicity up to six days [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

ABMA (2-200 mg/kg; intraperitoneal injection; female BALB/c mice) treatment protects mice from nasal instillation of an LD 90 of ricin [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Pathogen-free female BALB/c mice (6 week-old) with ricin [1]
Dosage: 2 mg/kg, 20 mg/kg, 200 mg/kg
Administration: Intraperitoneal injection
Result: A statistically significant protection according to survival curves was observed with a single ip dose of 2 mg/kg. The 20 mg/kg dose fully protected animals through to day 21. The 200 mg/kg dose resulted in 80% of protection of mice against ricin challenge with a single animal succumbing on day 15.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 125 mg/mL ( 356.85 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.8548 mL 14.2739 mL 28.5478 mL
5 mM 0.5710 mL 2.8548 mL 5.7096 mL
10 mM 0.2855 mL 1.4274 mL 2.8548 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 6.25 mg/mL (17.84 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 6.25 mg/mL (17.84 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 6.25 mg/mL (17.84 mM); Clear solution

* All of the co-solvents are available by MCE.